iShares Biotechnology ETF $IBB Shares Bought by Hamilton Wealth LLC

Hamilton Wealth LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 89.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,638 shares of the financial services provider’s stock after buying an additional 30,051 shares during the period. iShares Biotechnology ETF accounts for approximately 2.0% of Hamilton Wealth LLC’s investment portfolio, making the stock its 15th largest position. Hamilton Wealth LLC’s holdings in iShares Biotechnology ETF were worth $10,740,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the second quarter valued at approximately $25,000. Basepoint Wealth LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter worth approximately $26,000. Cary Street Partners Financial LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth $29,000. Copia Wealth Management acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth $34,000. Finally, Caitlin John LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth $34,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $173.64 on Friday. iShares Biotechnology ETF has a 52 week low of $123.61 and a 52 week high of $179.64. The stock’s fifty day moving average is $170.57 and its two-hundred day moving average is $170.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a dividend of $0.0238 per share. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.